Selective Endocannabinoid Re-uptake Inhibitors (SERIs): A New Class of ECS Modulators for Safe & Effective Treatment of Neuropsychiatric Disorders
Time: 3:15 pm
day: Conference Day 1
Details:
- Presenting the mode of action of SERIs to inhibit eCB re-uptake across plasma membranes by targeting a newly identified protein in the ECS
- SERIs represent a new class of ECS modulators characterized by a distinctive pharmacology profile within the ECS
- Showcasing SYT-510, a clinical candidate of the SERI class.
